J 2021

Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study

BÚŘIL, Jiří, Petra BÚŘILOVÁ, Andrea POKORNÁ, Ingrid KOVACOVA, Marek BALÁŽ et. al.

Basic information

Original name

Representation of Parkinson's disease and atypical Parkinson's syndromes in the Czech Republic-A nationwide retrospective study

Authors

BÚŘIL, Jiří (203 Czech Republic, guarantor, belonging to the institution), Petra BÚŘILOVÁ (203 Czech Republic, belonging to the institution), Andrea POKORNÁ (203 Czech Republic, belonging to the institution), Ingrid KOVACOVA (203 Czech Republic) and Marek BALÁŽ (703 Slovakia, belonging to the institution)

Edition

Plos one, San Francisco, Public Library of Science, 2021, 1932-6203

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30210 Clinical neurology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.752

RIV identification code

RIV/00216224:14110/21:00121355

Organization unit

Faculty of Medicine

DOI

UT WoS

000616736200026

Keywords in English

Parkinson's disease; atypical Parkinson's syndromes

Tags

Tags

International impact, Reviewed
Změněno: 7/4/2021 10:28, Mgr. Tereza Miškechová

Abstract

V originále

Background Parkinson's disease is a progressive neurodegenerative disease which causes health problem that affects more patients in the past few years. To be able to offer appropriate care, epidemiological analyses are crucial at the national level and its comparison with the international situation. Aim The demographic description of reported patients with parkinsonism (including Parkinson's disease and atypical parkinsonian syndromes) according to the International Classification of Diseases (ICD-10) from the national health registries. Methods Retrospective analysis of data available from the National Health Information System-NHIS and the National Registry of Reimbursed Health Services (NRRHS). Analyzed epidemiological data are intending to determine the regional and specific prevalence of Parkinsonism in the Czech Republic. The International Classification of Diseases diagnoses (ICD-10) of G20 (Parkinson's disease-PD) and G23.1, G23.2, G23.3 (other degenerative disorders of basal ganglia), and G31.8 (another degenerative disease of basal ganglia) from the period of 2012 to 2018 were included into the analysis. Results We identified 78 453 unique patients from national registries in the period 2012 to 2018. Diagnoses of G20, G23.1, G23.2, and G31.8 were registered as the principal diagnoses in 76.6% of all individual patients. Conclusion We have found a growing number of patients coded with ICD-10 of dg. G20, G23.1, G23.2, G23.3, or G31.8 (N = 27 891 in 2012, and N = 30 612 in 2018). We have proven regional differences in the prevalence of Parkinson ' s diagnoses. Therefore we assume most likely also differences in the care of patients with PD based on the availability of specialty care centers.